- admin
- Apr 08, 2026
What is Lagevrio (Molnupiravir)?
Lagevrio, the brand name for Molnupiravir, is an oral antiviral medication used to treat mild to moderate COVID-19 in adults who are at risk of developing severe illness. It helps reduce the chances of hospitalization and complications when taken early in the infection.
This medication is typically prescribed for individuals who cannot use other COVID-19 treatments or where alternative therapies are not suitable.
How Lagevrio Works
Molnupiravir works by interfering with the virus’s ability to replicate. It introduces errors into the genetic material of the virus, preventing it from multiplying effectively inside the body.
This action helps lower the viral load and supports the immune system in fighting the infection more efficiently.
Uses of Lagevrio
1. COVID-19 Treatment
Lagevrio is primarily used for treating mild to moderate COVID-19 in high-risk patients.
2. Reducing Hospitalization Risk
It helps decrease the likelihood of severe disease progression when taken within the early days of symptoms.
3. Alternative Antiviral Option
It is used when other COVID-19 treatments are not accessible or appropriate.
Lagevrio Dosage
Standard Adult Dose
- 800 mg (four 200 mg capsules) taken twice daily
- Duration: 5 days
Important Instructions
- Start treatment within 5 days of symptom onset
- Swallow capsules whole (do not crush or chew)
- Complete the full course even if you feel better
Benefits of Lagevrio
- Convenient oral treatment (no injections required)
- Helps reduce severity of COVID-19
- Lowers risk of hospitalization
- Suitable for high-risk individuals
Side Effects of Molnupiravir
Common Side Effects
- Diarrhea
- Nausea
- Dizziness
- Headache
Serious Side Effects (Rare)
- Allergic reactions
- Severe gastrointestinal symptoms
Seek immediate medical help if serious symptoms occur.
Precautions and Warnings
Before taking Lagevrio, consider the following:
- Not recommended during pregnancy due to potential risk to the fetus
- Use effective contraception during and after treatment
- Not authorized for use in individuals under 18 years
- Inform your doctor about existing medical conditions
Who Should Avoid Lagevrio?
Lagevrio may not be suitable for:
- Pregnant individuals
- Children and adolescents under 18
- People allergic to Molnupiravir or its ingredients
Drug Interactions
Currently, Molnupiravir has a low potential for drug interactions. However, always inform your healthcare provider about any medications or supplements you are taking.
Conclusion
Lagevrio (Molnupiravir) is an effective oral antiviral option for treating COVID-19 in high-risk adults. When taken early, it can significantly reduce the risk of severe illness and hospitalization. However, it must be used under medical supervision, with careful attention to dosage and safety guidelines.
FAQs
1. What is Lagevrio used for?
It is used to treat mild to moderate COVID-19 in adults at risk of severe illness.
2. How quickly should I start taking Molnupiravir?
It should be started within 5 days of symptom onset for best results.
3. Can Lagevrio prevent COVID-19?
No, it is not approved for prevention—only for treatment.
4. Is Molnupiravir safe during pregnancy?
No, it is generally not recommended during pregnancy due to potential risks.
5. Can I stop taking it early if I feel better?
No, you should complete the full 5-day course.
6. Does Lagevrio cure COVID-19?
It helps reduce severity but is not a guaranteed cure.
7. Do I need a prescription for Lagevrio?
Yes, it is a prescription-only medication.